Skip to main content
. 2020 Feb;49(2):257–266.

Table 1:

The comparison of the clinical data of the patients in two groups [n (%)]

Variable The study group (n=287) The control group (n=200) t/2 P
Age (yr) 47.82±10.54 46.33±9.84 1.577 0.116
BMI (kG/m2) 22.84±4.2 22.17±5.04 1.592 0.112
Platelet (×109cells/L) 228.21±50.14 220.42±57.21 1.591 0.112
Red blood cell (×1012cells/L) 4.66±0.64 4.72±0.51 1.104 0.270
White blood cell (×109cells/L) 8.15±1.17 7.96±1.34 1.660 0.098
Gender: Male 184 (64.11) 142 (71.00) 2.527 0.112
  Female 103 (35.89) 58 (29.00)
Nationality: Han nationality 282 (98.26) 198 (99.00) 0.458 0.498
  Minority 5 (1.74) 2 (1.00)
Residence: City 235 (81.88) 172 (86.00) 1.456 0.228
  Countryside 52 (18.12) 28 (14.00)
Marriage: Married 261 (90.94) 175 (87.50) 1.488 0.223
  Unmarried 26 (9.06) 25 (12.50)
Smoking: Yes 197 (68.64) 150 (75.00)
  No 90 (31.36) 50 (25.00)
Drinking: Yes 212 (73.87) 142 (71.00) 0.488 0.485
  No 75 (26.13) 58 (29.00)
Exercise: Yes 31 (10.80) 26 (13.00) 0.551 0.458
  No 256 (89.20) 174 (87.00)
TNM staging*: I∼II 168 (58.54)
  III∼IV 119 (41.46)
Differentiation degree
Middle differentiation and low differentiation 157 (54.70)
High differentiation 130 (45.30)
Lymph node metastasis
Yes 108 (37.63)
No 179 (62.37)
Infiltration degree
Infiltrating to serosa 139 (48.43)
Not infiltrating to serosa 148 (51.57)
The type of tumor
Villous adenoma 125 (43.55)
Villous adenoma 125 (43.55)

Note: TNM staging criteria refer to AJCC cancer staging manual (14)